[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345454-105":59,"doc-detail-345454-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","genetic-variations-in-the-fibronectin-1-gene-fn1-and-risk-of-female-reproductive-cancers-a-preliminary-study","Genetic Variations in the Fibronectin 1 Gene (FN1) and Risk of Female Reproductive Cancers - A Preliminary Study","","Investigates five single-nucleotide variants (SNVs) of the FN1 gene in female reproductive organ cancers. The study includes 208 women diagnosed with cervical, uterine, and ovarian cancers and 208 age-matched cancer-free controls. Genomic DNA from whole blood was analyzed using PCR/RFLP for five intronic SNVs. Two variants may increase gynecological cancer risk in dominant and log-additive models, and an AGATC haplotype showed higher frequency in overall cases, while Bonferroni correction removed significance after multiple testing.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/genetic-variations-in-the-fibronectin-1-gene-fn1-and-risk-of-female-reproductive-cancers-a-preliminary-study/345454/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/genetic-variations-in-the-fibronectin-1-gene-fn1-and-risk-of-female-reproductive-cancers-a-preliminary-study/345454.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main genetic focus of the study?","Question",{"text":112,"@type":113},"The study focused on five intronic single-nucleotide variants (SNVs) of the FN1 gene and their association with female reproductive organ cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the genetic variants analyzed?",{"text":117,"@type":113},"Genomic DNA from whole blood was used to analyze the five FN1 intronic SNVs using PCR/RFLP.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results suggest about FN1 variants and cancer risk?",{"text":121,"@type":113},"The rs6725958 and rs1968510 FN1 variants showed signals for slightly increased risk of female reproductive system cancers, particularly ovarian cancer, though significance did not persist after Bonferroni correction for multiple testing.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345454,1790466084,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Article  \nGenetic Variations in the Fibronectin 1 Gene (FN1) and Risk of Female Reproductive Cancers—A Preliminary Study  \nPiotr Pawlik 1, Grayna Kurzawi ´nska 2,3, Marcin Oarowski 4, *, Tomasz M. Karpi ´nski 5, Anna Bogacz 6, Piotr J. Olbromski 1, Aleksandra E. Mrozikiewicz 7, Maciej Bra˛zert 7, Wiesław Markwitz 2 and Agnieszka Seremak-Mrozikiewicz 2,3  \nAcademic Editor: Kuo-Hu Chen  \nReceived: 12 April 2026  \nRevised: 8 May 2026  \nAccepted: 10 May 2026  \nPublished: 12 May 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Obstetrics and Gynecology, District Public Hospital in Poznan, Juraszów 7/19, 60-479 Poznan, Poland; [pitpawlik@gmail.com](pitpawlik@gmail.com) (P.P.); [olbromski.piotr@gmail.com](olbromski.piotr@gmail.com) (P.J.O.)  \n2 Department of Perinatology, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland; [gkurzawinska@ump.edu.pl](gkurzawinska@ump.edu.pl) (G.K.); [wmarkwitz@ump.edu.pl](wmarkwitz@ump.edu.pl) (W.M.); [asm@data.pl](asm@data.pl) (A.S.-M.)  \n3 Laboratory of Molecular Biology, Department of Perinatology, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland  \n4 Department of Biotechnology, Institute of Natural Fibres and Medicinal Plants—National Research Institute, Wojska Polskiego 71b, 60-630 Poznan, Poland  \n5 Department of Medical Microbiology, Medical Faculty, Poznan University of Medical Sciences, Rokietnicka 10, 60-806 Poznan, Poland; [tkarpin@ump.edu.pl](tkarpin@ump.edu.pl)  \n6 Department of Cancer Immunology, Poznan University of Medical Sciences, Rokietnicka Street 8, 60-806 Poznan, Poland; [anna.bogacz@ump.edu.pl](anna.bogacz@ump.edu.pl)  \n7 Department of Diagnostics and Treatment of Infertility, Poznan University of Medical Sciences, Polna 33,  \n60-535 Poznan, Poland; [a.mrozikiewicz@ump.edu.pl](a.mrozikiewicz@ump.edu.pl) (A.E.M.); [maciejbrazert@ump.edu.pl](maciejbrazert@ump.edu.pl) (M.B.)  \n* [Correspondence: marcin.ozarowski@iwnirz.pl](Correspondence: marcin.ozarowski@iwnirz.pl)  \nAbstract  \nWe investigated five single-nucleotide variants (SNVs) of the FN1 gene in female reproductive organ cancers. The proteins expressed by this gene are essential components of the extracellular matrix (ECM) that constitutes the tumor microenvironment (TME). The study group included 208 women diagnosed with cervical, uterine, and ovarian cancers and 208 age-matched cancer-free controls. Genomic DNA from whole blood was used to analyze five intronic SNVs of the FN1 gene using PCR/RFLP. The results indicate that two of the studied FN1 gene variants may increase the risk of gynecological cancers in dominant and log-additive models (p = 0.048 and p = 0.040 for rs6725958, p = 0.033 and p = 0.038 for rs1968510, respectively) . Comparing individual cancer groups with the controls, differences were observed for the ovarian cancer group (rs1968510 p = 0.015 and p = 0.016, rs6725958 p = 0.070 and p = 0.037 in dominant and log-additive models, respectively) . None of these associations remained statistically significant after Bonferroni correction for multiple testing. Haplotype analyses revealed that the AGATC haplotype, containing minor alleles for rs35343655 and rs6725958, was more frequent in the entire gynecological cancer group (p = 0.0036) . For individual cancer types, values of p = 0.0071 for ovarian, p = 0.0028 for endometrial, and p = 0.0269 for cervical cancers were obtained; Our preliminary study suggests that the rs6725958 and rs1968510 FN1 variants may slightly increase the risk of female reproductive system cancers, particularly ovarian cancer. These findings require further validation in larger, independent cohorts and functional studies.  \nKeywords: SNV; FN1 gene; gynecologic cancer  \n1. Introduction  \nThe most common malignant tumors of the female reproductive system, with a significant","cbCaioBn4o9zVbgG","https://ap.wps.com/l/cbCaioBn4o9zVbgG","pdf",598947,16,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"What was the main genetic focus of the study?\",\"answer\":\"The study focused on five intronic single-nucleotide variants (SNVs) of the FN1 gene and their association with female reproductive organ cancers.\"},{\"question\":\"How were the genetic variants analyzed?\",\"answer\":\"Genomic DNA from whole blood was used to analyze the five FN1 intronic SNVs using PCR/RFLP.\"},{\"question\":\"What did the results suggest about FN1 variants and cancer risk?\",\"answer\":\"The rs6725958 and rs1968510 FN1 variants showed signals for slightly increased risk of female reproductive system cancers, particularly ovarian cancer, though significance did not persist after Bonferroni correction for multiple testing.\"}]","Genetic Variations in the Fibronectin 1 Gene (FN1) and Risk of Female Reproductive Cancers - A Preliminary Study | PDF",1790057708,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64c892e997c9e62b1a330a34b08ca38d.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5616643e6bf2029efab66632233dfaa.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff140e74c582023b6280a6be76b6cd2d.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88fb8b038679e6f3f30045ee692f0075.webp",980,1385]